Vemurafenib and Obinutuzumab in Hairy Cell Leukemia Patients @sloan_kettering

Vemurafenib and Obinutuzumab in Hairy Cell Leukemia Patients @sloan_kettering

obr

3 months
9 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jae H. Park, MD, Associate, Leukemia Service, Department of Medicine, @sloan_kettering shares clinical outcomes from the investigation of the vemurafenib combined with obinutuzumab in patients with hairy cell leukemia.
Up Next Autoplay